Search results
Results from the WOW.Com Content Network
ROME (Reuters) -Italy's antitrust regulator said on Thursday it had launched an investigation into pharmaceutical companies including Novartis and Roche-controlled Genentech for having potentially ...
President-elect Donald Trump dispelled rumors Monday that his administration would seek to ban the polio vaccine, telling reporters Monday, "that's not going to happen." Trump's nominee for ...
The biopharmaceutical unit was integrated into Novartis Pharmaceuticals, while the vaccines and blood testing units were made into a new Novartis Vaccines and Diagnostics division. [34] Also in 2006, Sandoz became the first company to have a biosimilar drug approved in Europe with its recombinant human growth hormone drug.
The book addresses misinformation related to vaccination, and asks how vaccine rumors start and why they do not go away. [1] [4] Looking chiefly at high-income countries, the book examines social, political, psychological and cultural factors that make up the various mind-sets to vaccination. [2]
(Reuters) -Drug maker Novartis AG is in advanced talks to acquire MorphoSys AG, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar ...
Novartis shareholders are due to vote on the Sandoz spin-off at an extraordinary general meeting on Sept. 15, with the first day of trading scheduled for Oct 4. (Reporting by Ludwig Burger and ...
Novartis and Viatris were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and ...
Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases.